Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2

Bibliographic Details
Main Authors:	Yang Yang, Xiaohua Gong, Jun Wang, Shisong Fang, Jiaqi Zhang, Xuejiao Liao, Yuan Guan, Weihua Wu, Yingxia Liu, Hongzhou Lu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-09-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-022-01166-w

Similar Items

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
by: Xun Wang, et al.
Published: (2022-10-01)

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
by: Jinyoung Yang, et al.
Published: (2023-03-01)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2023-02-01)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
by: Maren Bormann, et al.
Published: (2023-07-01)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
by: Rune M. Pedersen, et al.
Published: (2022-12-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
by: Jing Zou, et al.
Published: (2022-05-01)

Comparison of Neutralizing Activity between Vaccinated and Unvaccinated Hospitalized COVID-19 Patients Infected with Delta, Omicron BA.1, or Omicron BA.2 Variant
by: Keun Ju Kim, et al.
Published: (2024-03-01)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
by: Khadija Khan, et al.
Published: (2022-08-01)

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
by: Chaitanya Kurhade, et al.
Published: (2022-06-01)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
by: Annika Rössler, et al.
Published: (2022-12-01)

Antibody response and cross-neutralization after Omicron BA.2 infection
by: Yiwen Zhang, et al.
Published: (2023-01-01)

Virological Characteristics of Five SARS-CoV-2 Variants, Including Beta, Delta and Omicron BA.1, BA.2, BA.5
by: Yan Zeng, et al.
Published: (2023-12-01)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
by: Emanuele Andreano, et al.
Published: (2022-06-01)

Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children
by: Xiaohe Li, et al.
Published: (2022-06-01)

Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections
by: Bin Ju, et al.
Published: (2022-11-01)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection
by: Chengzi I. Kaku, et al.
Published: (2023-05-01)

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
by: Mingxi Li, et al.
Published: (2022-12-01)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
by: Delphine Planas, et al.
Published: (2023-02-01)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
by: Iris Medits, et al.
Published: (2022-07-01)

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
by: Yingdan Wang, et al.
Published: (2022-10-01)

Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2022-07-01)

Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
by: Khadija Khan, et al.
Published: (2022-10-01)

Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
by: Nicole Wolter, et al.
Published: (2022-10-01)

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
by: Ruopeng Xie, et al.
Published: (2023-04-01)

Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5
by: Yanqun Wang, et al.
Published: (2023-01-01)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
by: Jeffrey Seow, et al.
Published: (2023-10-01)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
by: Chengzhuo Tong, et al.
Published: (2022-09-01)

Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark
by: Kimihito Ito, et al.
Published: (2022-06-01)

Omicron BA.2 to dominate in Malaysia
by: Teoh, Pei Ying
Published: (2022)

Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
by: Jianhua Li, et al.
Published: (2022-12-01)

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination
by: Lorenza Bellusci, et al.
Published: (2022-08-01)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: T. Selvavinayagam, Sivaprakasam, et al.
Published: (2022)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022-09-01)

Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
by: Rune M. Pedersen, et al.
Published: (2022-06-01)

Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients
by: Cho-Chin Cheng, et al.
Published: (2022-08-01)

Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage
by: Jidapa Szekely, et al.
Published: (2023-07-01)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
by: Stijn P. Andeweg, et al.
Published: (2022-08-01)

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
by: Carolina Torres, et al.
Published: (2023-01-01)